Day One Biopharmaceuticals
DAWN • NASDAQ
Day One Biopharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeremy Bender, with a market cap of $2.2B.
CEOJeremy Bender
Next Earnings
Upcoming earnings announcement for Day One Biopharmaceuticals
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.23
Revenue Estimate
$53.9M
Earnings History
Past 12 earnings reports for Day One Biopharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$0.21Est: -$0.16 | -31.2% | $53.7MEst: $48.6M | +10.5% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.19Est: -$0.28 | +32.1% | $39.8MEst: $37.8M | +5.4% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.29Est: -$0.35 | +17.1% | $33.9MEst: $34.8M | -2.6% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.35Est: -$0.44 | +20.5% | $30.8MEst: $30.3M | +1.6% | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$0.69Est: -$0.35 | -97.1% | $29.2MEst: $27.8M | +5.1% | 10-K/A |
| Oct 30, 2024 | Q3 2024 | $0.38Est: -$0.41 | +192.7% | $93.8MEst: $23.5M | +298.3% | 10-Q |
| Jul 30, 2024 | Q2 2024 | -$0.05Est: -$0.62 | +91.9% | $8.2MEst: $1.0M | +703.1% | 10-Q |
| May 6, 2024 | Q1 2024 | -$0.72Est: -$0.66 | -9.1% | - | — | 10-Q |
| Feb 26, 2024 | Q4 2023 | -$0.64Est: -$0.58 | -10.3% | - | — | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.54Est: -$0.60 | +10.0% | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$0.61Est: -$0.61 | 0.0% | - | — | — |
| May 1, 2023 | Q1 2023 | -$0.59 | — | - | — | — |